China Accounts Payable vs Cash Analysis

600511 Stock   32.56  0.18  0.55%   
China National financial indicator trend analysis is way more than just evaluating China National Medicines prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China National Medicines is a good investment. Please check the relationship between China National Accounts Payable and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Cash

Accounts Payable vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China National Medicines Accounts Payable account and Cash. At this time, the significance of the direction appears to have almost identical trend.
The correlation between China National's Accounts Payable and Cash is 0.93. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of China National Medicines, assuming nothing else is changed. The correlation between historical values of China National's Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of China National Medicines are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., China National's Accounts Payable and Cash go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Accounts Payable

An accounting item on the balance sheet that represents China National obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of China National Medicines are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash

Cash refers to the most liquid asset of China National Medicines, which is listed under current asset account on China National Medicines balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from China National customers. The amounts must be unrestricted with restricted cash listed in a different China National account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from China National's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China National Medicines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China National Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of January 6, 2025, Selling General Administrative is expected to decline to about 459.3 M. In addition to that, Tax Provision is expected to decline to about 495.7 M
 2022 2023 2024 2025 (projected)
Operating Income2.4B2.5B2.8B3.0B
Total Revenue45.5B49.7B57.2B60.0B

China National fundamental ratios Correlations

0.070.971.00.960.980.960.750.96-0.071.00.70.890.98-0.430.990.870.480.920.93-0.90.910.860.940.910.84
0.070.190.010.19-0.090.130.320.150.880.110.420.18-0.03-0.160.16-0.220.130.30.21-0.380.160.270.17-0.13-0.33
0.970.190.961.00.940.970.851.00.020.970.720.90.96-0.470.970.820.510.890.92-0.910.870.840.960.840.76
1.00.010.960.960.990.960.720.96-0.130.990.670.890.99-0.430.980.890.470.90.92-0.860.910.850.940.920.86
0.960.191.00.960.930.970.850.990.020.960.710.90.96-0.460.970.820.510.880.92-0.90.870.850.960.840.76
0.98-0.090.940.990.930.940.710.94-0.230.970.610.850.99-0.430.960.910.440.860.89-0.820.870.80.910.920.88
0.960.130.970.960.970.940.760.97-0.010.960.750.910.96-0.30.940.880.630.870.91-0.860.880.810.920.850.79
0.750.320.850.720.850.710.760.860.250.770.650.710.72-0.430.80.480.480.710.7-0.830.580.670.770.560.44
0.960.151.00.960.990.940.970.860.020.960.720.910.96-0.430.970.820.550.870.91-0.90.860.850.950.840.76
-0.070.880.02-0.130.02-0.23-0.010.250.02-0.020.350.04-0.180.110.0-0.350.160.150.04-0.26-0.030.160.0-0.25-0.47
1.00.110.970.990.960.970.960.770.96-0.020.730.890.97-0.420.990.840.490.930.93-0.920.90.860.940.890.81
0.70.420.720.670.710.610.750.650.720.350.730.730.63-0.050.720.490.650.820.8-0.790.760.810.780.680.43
0.890.180.90.890.90.850.910.710.910.040.890.730.9-0.240.890.740.690.80.83-0.760.820.770.830.770.74
0.98-0.030.960.990.960.990.960.720.96-0.180.970.630.9-0.430.960.910.470.860.91-0.830.90.830.930.920.87
-0.43-0.16-0.47-0.43-0.46-0.43-0.3-0.43-0.430.11-0.42-0.05-0.24-0.43-0.49-0.250.39-0.46-0.470.51-0.43-0.43-0.49-0.37-0.33
0.990.160.970.980.970.960.940.80.970.00.990.720.890.96-0.490.80.450.940.93-0.930.90.870.950.870.8
0.87-0.220.820.890.820.910.880.480.82-0.350.840.490.740.91-0.250.80.460.70.79-0.630.790.670.80.870.81
0.480.130.510.470.510.440.630.480.550.160.490.650.690.470.390.450.460.340.36-0.360.330.320.380.330.34
0.920.30.890.90.880.860.870.710.870.150.930.820.80.86-0.460.940.70.340.97-0.950.950.950.950.870.69
0.930.210.920.920.920.890.910.70.910.040.930.80.830.91-0.470.930.790.360.97-0.910.980.960.990.930.75
-0.9-0.38-0.91-0.86-0.9-0.82-0.86-0.83-0.9-0.26-0.92-0.79-0.76-0.830.51-0.93-0.63-0.36-0.95-0.91-0.84-0.89-0.91-0.77-0.6
0.910.160.870.910.870.870.880.580.86-0.030.90.760.820.9-0.430.90.790.330.950.98-0.840.940.950.950.79
0.860.270.840.850.850.80.810.670.850.160.860.810.770.83-0.430.870.670.320.950.96-0.890.940.930.880.66
0.940.170.960.940.960.910.920.770.950.00.940.780.830.93-0.490.950.80.380.950.99-0.910.950.930.930.76
0.91-0.130.840.920.840.920.850.560.84-0.250.890.680.770.92-0.370.870.870.330.870.93-0.770.950.880.930.86
0.84-0.330.760.860.760.880.790.440.76-0.470.810.430.740.87-0.330.80.810.340.690.75-0.60.790.660.760.86
Click cells to compare fundamentals

China National Account Relationship Matchups

China National fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets24.9B27.5B29.6B32.5B37.3B39.2B
Other Current Liab1.2B1.5B1.0M1.2M1.4M1.3M
Total Current Liabilities11.2B12.7B12.7B13.9B16.0B16.8B
Total Stockholder Equity11.4B12.8B14.2B15.8B18.1B19.0B
Accounts Payable9.0B10.1B9.9B10.9B12.6B13.2B
Cash6.2B7.3B8.9B10.9B12.6B13.2B
Other Assets242.6M283.9M299.0M345.4M397.2M417.1M
Net Receivables5.4B5.7B5.7B9.0B10.3B10.8B
Inventory3.0B3.5B3.7B4.0B4.6B4.8B
Other Current Assets198.6M280.6M14.5M8.7M10.0M9.5M
Total Liab11.8B13.1B13.7B14.9B17.2B18.0B
Property Plant Equipment628.5M832.7M895.7M845.1M971.8M1.0B
Retained Earnings8.3B9.7B10.5B12.0B13.8B14.5B
Intangible Assets330.4M326.2M330.9M386.1M444.0M466.2M
Other Liab233.2M265.0M313.7M718.4M826.2M867.5M
Net Tangible Assets8.8B10.1B11.0B12.3B14.2B9.2B
Other Stockholder Equity15.9M22.5M27.7M24.9M22.4M25.5M
Deferred Long Term Liab56.8M71.8M90.3M89.6M103.0M68.2M
Total Current Assets22.1B24.5B25.8B28.3B32.5B22.0B
Non Current Assets Total2.8B3.0B3.8B4.2B4.8B3.0B
Non Currrent Assets Other674.8M139.6M686.7M686.0M789.0M828.4M
Non Current Liabilities Total573.8M491.1M1.0B1.0B1.2B1.2B
Non Current Liabilities Other178.1M226.6M215.2M747.1M859.2M902.2M
Net Invested Capital11.9B13.2B14.5B16.0B18.5B13.5B
Short Long Term Debt471.8M428.8M252.1M268.4M241.5M456.0M
Net Working Capital10.9B11.8B13.0B14.4B16.5B12.1B
Property Plant And Equipment Net895.7M845.1M857.9M827.0M744.3M681.4M
Capital Lease Obligations260.1M197.3M182.6M205.1M184.6M161.9M
Property Plant And Equipment Gross1.3B1.4B1.4B827.0M744.3M992.3M

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China National Medicines at a specified time, usually calculated after every quarter, six months, or one year. China National Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China National and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.